✦ LIBER ✦

96 A Randomized, Controlled, Double-Blind Clinical Trial of Rikkunshito Versus Placebo for Gastrointestinal Symptoms and Quality of Life in Patients With Proton Pump Inhibitor -Refractory Non-Erosive Reflux Disease: The G-Pride Study

✍ Scribed by Kato, Mototsugu; Takeda, Hiroshi; Tominaga, Kazunari; Kusunoki, Hiroaki; Furuta, Kenji; Sakurai, Kouichi; Odaka, Takeo; Kinoshita, Yoshikazu; Haruma, Ken; Takahashi, Shin'ichi; Higuchi, Kazuhide; Kusano, Motoyasu; Fujimoto, Kazuma; Arakawa, Tetsuo

Book ID: 123113726
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 209 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)60076-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, placebo-controlled, double

A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study

✍ Tominaga, Kazunari; Kato, Mototsugu; Takeda, Hiroshi; Shimoyama, Yasuyuki; Umega 📂 Article 📅 2014 🏛 Springer Japan 🌐 English ⚖ 619 KB

Randomised clinical trial: a multicentre

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

✍ Y. Kinoshita; K. Ashida; M. Hongo; The Japan Rabeprazole Study Group for NERD 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB